Observational studyTransplant infectious disease : an official journal of the Transplantation Society2019

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience.

Andrew Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.